Tarsus Pharmaceuticals, Inc. (TARS) Misses Q4 EPS by 12c Feb 24, 2026 12:44AM
Mizuho Starts Tarsus Pharmaceuticals (TARS) at Outperform, 'Mite Be a Blockbuster: Bullish on Xdemvy' Nov 20, 2025 05:36AM
Tarsus Pharmaceuticals, Inc. (TARS) Tops Q3 EPS by 5c Nov 4, 2025 04:28PM
Tarsus Pharmaceuticals (TARS) PT Raised to $88 at H.C. Wainwright Oct 20, 2025 06:09AM
Tarsus Pharmaceuticals, Inc. (TARS) Misses Q2 EPS by 10c Aug 6, 2025 06:21PM


Jun 2, 2025 08:56AM Oppenheimer assumes Tarsus Pharmaceuticals (TARS) at Outperform (correction)
May 27, 2025 06:06AM H.C. Wainwright Starts Tarsus Pharmaceuticals (TARS) at Buy
May 5, 2025 07:39AM Elanco Animal Health (ELAN) sells certain royalties and commercial milestones associated with XDEMVY to Blackstone Life Sciences and Blackstone Credit & Insurance for $295M Cash
Mar 12, 2025 04:13PM Tarsus Pharmaceuticals (TARS) Announces Proposed $100M Public Offering
Mar 6, 2025 12:59PM Tarsus Pharmaceuticals (TARS) PT Raised to $58 at Jefferies
Feb 26, 2025 07:26AM Tarsus Pharmaceuticals (TARS) PT Raised to $78 at Guggenheim
Feb 26, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
Feb 25, 2025 04:27PM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q4 EPS by 17c
Jan 22, 2025 06:27AM Tarsus Pharmaceuticals (TARS) PT Raised to $72 at Oppenheimer
Jan 15, 2025 05:04AM Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)
Jan 13, 2025 08:37AM Tarsus Pharmaceuticals (TARS) Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care
Nov 29, 2024 08:31AM Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
Nov 15, 2024 06:51AM Tarsus Pharmaceuticals (TARS) PT Raised to $73 at H.C. Wainwright
Nov 13, 2024 05:34PM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q3 EPS by 33c
Nov 13, 2024 08:30AM Tarsus Pharmaceuticals (TARS) Appoints Kate Goodrich to its Board
Nov 5, 2024 08:30AM Tarsus Pharmaceuticals (TARS) Appoints Elizabeth Yeu as Chief Medical Officer
Oct 22, 2024 06:27AM Oppenheimer Reiterates Outperform Rating on Tarsus Pharmaceuticals (TARS)
Oct 11, 2024 07:23AM Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
Oct 4, 2024 06:55AM Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
Sep 23, 2024 07:33AM Oppenheimer Reiterates Outperform Rating on Tarsus Pharmaceuticals (TARS)
Aug 9, 2024 06:37AM Tarsus Pharmaceuticals, Inc. (TARS) Tops Q2 EPS by 4c
Feb 9, 2024 08:00PM 4 small and mid-cap biopharma stocks to own according to BofA